Skip to content

Impact of HIV Self-testing Among Female Sex Workers in Kampala, Uganda

The Causal Impact of HIV Self-testing Among Female Sex Workers in Kampala, Uganda

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02846402
Acronym
HSPOT
Enrollment
960
Registered
2016-07-27
Start date
2016-09-30
Completion date
2017-06-30
Last updated
2018-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infection

Keywords

HIV testing, Female sex workers, HIV self-testing

Brief summary

HSPOT is a cluster-randomized trial designed to determine whether HIV self-tests are acceptable and improve HIV testing rates and HIV status knowledge among female sex workers in Kampala, Uganda. This study will determine whether directly giving participants an HIV self-test or giving them a coupon to collect a test at a drug store or clinic improves outcomes compared to standard of care.

Detailed description

Although Uganda has a generalized HIV epidemic, with approximately 7.4% of adults aged 15 to 49 living with HIV, the epidemic remains even more highly concentrated in key populations, including female sex workers (FSW). A particular concern for FSW is access to healthcare services, including HIV testing services. FSW face significant barriers to accessing healthcare. In other settings, evidence has suggested that stigma is a significant barrier to FSW seeking HIV testing. It is likely that similar mechanisms exist in Uganda. Evidence from Uganda has indicated that complex multilevel factors, such as stigmatization and harassment, contribute to vulnerability among FSW. User-controlled HIV prevention interventions that lead to empowerment of FSW may therefore be a powerful way to address the HIV epidemic in this key population. Oral HIV self-testing consists of an oral swab kit that allows individuals to test for HIV in the privacy of their own homes whenever they want. The ease of use of HIV self-testing, that it can be done at any time, and that is completely private may make it an attractive alternative to currently-available HIV testing mechanisms for FSW in Uganda. HIV self-testing has generally been shown to be acceptable in a variety of populations, however evidence related to its uptake and acceptability remain sparse, especially among key populations and in Sub-Saharan Africa. This research will provide rigorous evidence of the uptake and efficacy of HIV self-testing for this population. HSPOT was designed to determine whether either direct distribution of HIV self-test kits via peer educators or distribution of HIV self-tests via coupons that participants can use to collect kits at collection points such as drug stores or health posts leads to better coverage of HIV testing and better awareness of HIV status. HSPOT is a cluster-randomized trial in which peer educators recruit a small group of FSW participants, and the peer educator group is randomized to one of three study arms: 1) direct distribution of test kits, 2) fixed distribution of test kits, or 3) referral to standard of care HIV testing. The primary outcome is HIV testing in the past month measured at one and four months after the first peer educator visit (when the test kits or coupons are distributed in the intervention arms).

Interventions

The Oral HIV Self-Test is an in-home test that uses an oral swab to collect samples of oral mucosa that is used to detect the presence of HIV antibodies. The test is read after 20 minutes by the user. The test can be done by an individual at any time and place of the user's choosing. The test is read visually.

Sponsors

Uganda Health Marketing Group
CollaboratorUNKNOWN
International Research Consortium
CollaboratorUNKNOWN
International Initiative for Impact Evaluation
CollaboratorOTHER
Harvard School of Public Health (HSPH)
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

1:1:1 cluster randomized controlled trial

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 18 years of age or older on the enrollment visit date * Reports exchanging sex (vaginal, anal, and/or oral) for money or goods at least once in the past month * Self-reported HIV negative status and no recent (\<3 months) HIV testing OR self-reported HIV unknown status * Member of the hot spot where recruited for at least one month AND plans on remaining in the area for the next 4 months * Have never used an oral HIVST kit * Willing to participate in peer education sessions on a monthly basis over the 4-month study period and to participate in study assessments * Of sound mind and not under influence of drugs or coercion

Exclusion criteria

* Less than 18 years of age on the enrollment date * Has not exchanged any form of sex in the past one month * Self-reported to be living with HIV * Self-reported HIV negative status and reports testing within the last 3 months * Planning to move out of geographic area within 4 months * Concurrently participating in another HIV prevention study * Meets criteria but does not wish to participate * Not willing or able to provide informed consent

Design outcomes

Primary

MeasureTime frame
HIV testing in the previous monthOne month from first intervention visit

Secondary

MeasureTime frame
Knowledge of own HIV statusFour months from first intervention visit
HIV self-test kit use in the two intervention armsOne month from first intervention visit

Other

MeasureTime frame
Condom use with commercial sexual partners since last visitOne month from first intervention visit
Condom use with non-commercial sexual partners since last visitOne month from first intervention visit
Average number of commercial sexual partnersOne month from first intervention visit
Average number of non-commercial sexual partnersOne month from first intervention visit
Linkage to HIV care and confirmatory testingOne month from first intervention visit
HIV fatalismOne month from first intervention visit
Self-reported self-efficacy as measured by the General Self Efficacy ScaleOne month from first intervention visit
Female sex worker empowerment as measured by Beattie et al 2014One month from first intervention visit
Pre-exposure prophylaxis preferencesOne month from first intervention visit
Intimate partner violence, including sexual, physical, or verbalOne month from first intervention visit
HIV risk perception and beliefs about acquiring HIVOne month from first intervention visit
HIV disclosure with sexual partnersOne month from first intervention visit

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026